Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,377,699
in 4 filings, $108K under 10b5-1 plans

Net −$1,377,699. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-18 Schroeder Mark S EVP, Pres Diagnostics & COO Exercise or conversion · Non-qualified Stock Options 10b5-1 −1,500 1,900
2023-05-05 Schroeder Mark S EVP, Pres Diagnostics & COO Grant or award · Non-qualified Stock Options +1,400 1,400
2023-05-05 Schroeder Mark S EVP, Pres Diagnostics & COO Grant or award · Restricted Stock Unit +440 3,121
2023-05-05 Caveney Brian J EVP, Pres of ED, CMO & CSO Grant or award · Non-qualified Stock Options +1,000 1,000
2023-05-05 Caveney Brian J EVP, Pres of ED, CMO & CSO Grant or award · Restricted Stock Unit +300 2,981
2023-05-05 Bailey Megan D. EVP, Chief Strategy Officer Grant or award · Restricted Stock Unit +180 4,807
2023-05-05 Bailey Megan D. EVP, Chief Strategy Officer Grant or award · Non-qualified Stock Options +600 600
2023-05-05 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Grant or award · Non-qualified Stock Options +1,200 1,200
2023-05-05 DiVincenzo Jonathan P. EVP, Pres, Central Labs & Intl Grant or award · Restricted Stock Unit +370 1,664
2023-04-05 GRAHAM ANITA Z EVP, CHRO Grant or award · Non-qualified Stock Options +3,000 3,000
2023-04-05 GRAHAM ANITA Z EVP, CHRO Grant or award · Restricted Stock Unit +990 990
2023-03-31 Schroeder Mark S EVP, President-Diagnostics Lab Sale 10b5-1 −3,897 $225.81 $880K 6,687.4
2023-03-30 Schechter Adam H President & CEO Grant or award +42,353 65,534
2023-03-30 Schechter Adam H President & CEO Shares withheld for taxes −18,646 $224.70 $4.2M 46,888
2023-03-30 Kirchgraber Paul R CEO, Covance Drug Development Grant or award +6,763 15,832
2023-03-30 Kirchgraber Paul R CEO, Covance Drug Development Shares withheld for taxes −2,886 $224.70 $648K 12,946
2023-03-30 EISENBERG GLENN A Chief Financial Officer, EVP Grant or award +11,715 47,355
2023-03-30 EISENBERG GLENN A Chief Financial Officer, EVP Shares withheld for taxes −5,179 $224.70 $1.2M 42,176
2023-03-30 Caveney Brian J EVP, President of Diagnostics Grant or award +6,763 23,175.76
2023-03-30 Caveney Brian J EVP, President of Diagnostics Shares withheld for taxes −2,990 $224.70 $672K 20,185.76

Page 37 of 41 · 816 trades